PDC Therapeutics
PrivateLast Round
Series A
Dec 15, 2021
Total Funding Raised
$14.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PDC Therapeutics is a biotechnology company that develops targeted Polymer-Drug Conjugate technologies for cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PDC Therapeutics Comparables
Compare PDC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 82% | |
| Beihai Biotech | 77% | |
| OncoNano Medicine | 74% |
PDC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2021 |
PDC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Partners | Seed |
| İstanbul Portföy Yönetimi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 239% MoM, reaching 1.7K.
- May 11, 2026
Monthly visitors increased 374% MoM, from 358 to 1.7K.
PDC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PDC Therapeutics's valuation, stock price, and market status.
Is PDC Therapeutics a public or private company?
PDC Therapeutics is a private company.
What is the current stock price of PDC Therapeutics?
PDC Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is PDC Therapeutics worth (valuation)?
Valuation information for PDC Therapeutics is not publicly available.
Can I buy PDC Therapeutics stock?
PDC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PDC Therapeutics's last funding round?
PDC Therapeutics's most recent funding round was Series A on December 15, 2021.
Who are the main investors in PDC Therapeutics?
Key investors in PDC Therapeutics include ACT Venture Partners, İstanbul Portföy Yönetimi.
Will PDC Therapeutics IPO soon?
No public IPO plans have been announced for PDC Therapeutics.
How can I track PDC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PDC Therapeutics's secondary market activity and sign up for updates.